Position in CADL
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$324,038
+$221,805 QoQ
Shares Held
31,460
+50.8% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#75
of 138 holders
Holding Since
Mar 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AXQ CAPITAL, LP holds $45,364,119 across 106 Biotechnology names. CADL ranks #39 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
91,437 | $3,566,957 | |
| 2 | INSM |
INSMED Inc
|
22,813 | $2,432,322 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
30,831 | $2,413,142 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,952 | $1,840,690 | |
| 5 | MRNA |
Moderna, Inc.
|
22,477 | $1,574,064 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
39,712 | $1,405,407 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,797 | $1,389,353 | |
| 8 | SMMT |
Summit Therapeutics Inc.
|
93,624 | $1,364,101 |
All Filings in CADL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $324,038 | 31,460 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $102,233 | 20,864 | Shares | Sole | 2026-05-13 | |
| 2025-03-31 | $112,677 | 19,943 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||